Drug Discovery & DDS– category –
-
Drug Discovery & DDS
Asia-Pacific Revolutionizes Pharma Manufacturing: Surging Capabilities in HPAPIs, Biologics, and Advanced Therapies
BioProcess International Asia-Pacific Overview The Asia-Pacific (APAC) region is rapidly expanding its specialized pharmaceutical manufacturing capabilities beyond traditional APIs, focusing on high-value modalities like HPAPIs, ADCs, mR... -
Drug Discovery & DDS
AAV Vector Manufacturing Achieves Kilo-Scale Production with 2,000L+ Suspension Bioreactors, Solving Gene Therapy Bottleneck
Drug Discovery News USA Overview AAV upstream production has achieved significant scalability, with suspension bioreactors reaching over 2,000 liters using adapted HEK293 cells, providing volumetric capacity for clinical and commercial g... -
Drug Discovery & DDS
Tamarind Bio and GenScript Partner to Accelerate Drug Discovery by Connecting AI Molecular Design with Rapid Wet-Lab Validation
Facebook (from GenScript Biotech) USA Overview AI-driven drug design, particularly using generative models like GANs and VAEs, accelerates drug discovery by generating novel molecular structures with desired properties. These systems ana... -
Drug Discovery & DDS
Mannosylated Spleen-Targeted LNP (LNP-PAM) Enhances mRNA Delivery to Antigen-Presenting Cells, Overcoming Liver Tropism
ACS Publications USA Overview A novel mannosylated spleen-targeted lipid nanoparticle (LNP-PAM) has been developed to significantly enhance mRNA delivery to antigen-presenting cells by integrating active and endogenous targeting. This sy... -
Drug Discovery & DDS
Transferrin-Conjugated Polymeric Nanoparticles via PISA Enhance BBB Transport and Doxorubicin Delivery for Glioblastoma Therapy
ACS Publications USA Overview Researchers have developed transferrin-conjugated polymeric nanoparticles, synthesized via polymerization-induced self-assembly (PISA), for enhanced blood-brain barrier (BBB) penetration and glioblastoma (GB... -
Drug Discovery & DDS
Scaffold-Aware Transformer with Multi-Scale Attention Accelerates Novel Molecular Design
PMC (Part of MDPI) Switzerland Overview Researchers propose a novel framework for de novo molecular design that integrates a transformer-based generative model and a graph attention network-based predictive model, featuring a scaffold-aw... -
Drug Discovery & DDS
Structure-Aware AI Accelerates Next-Gen Drug Discovery: From 3D Molecular Geometry to Generative Biomolecular Design
Briefings in Bioinformatics | Oxford Academic UK Overview Structure-aware AI systems, leveraging graph neural networks, Transformer-based models, and diffusion-based generative models, are advancing next-generation drug discovery. These ... -
Drug Discovery & DDS
Montara Therapeutics Reimagines Blood-Brain Barrier as Solution, Not Problem, Secures $1M for Brain-Selective mTOR Therapy
Drug Discovery News USA Overview Montara Therapeutics is pioneering an approach to blood-brain barrier (BBB) drug delivery by leveraging the BBB to its advantage for brain-selective pharmacology. Instead of forcing drugs across, their te... -
Drug Discovery & DDS
Organ-on-Chip Platforms Accelerate Nanoparticle DDS Development: Revolutionizing Preclinical Predictive Power
Biophysics Reviews | AIP Publishing USA Overview While nanoparticle-based drug delivery systems (DDS) have advanced significantly, their preclinical evaluation's predictive power has been a bottleneck. The integration of nanoparticles wi... -
Drug Discovery & DDS
Antibiotics Reshape Gut Microbiome, Doubling Circulation Time and Tumor Accumulation of Nano-Chemotherapy, Improving Survival
University of Texas M. D. Anderson Cancer Center USA Overview Researchers at The University of Texas MD Anderson Cancer Center discovered that reshaping the gut microbiome with a short course of antibiotics can enhance the delivery of na...